Tyrosine kinase participates in α(1A)-adrenoceptor-mediated increase of intracellular calcium in human embryo kidney 293 cells

Weizhong Zhu,BenBo Gao,Hewang Li,Youyi Zhang,QiDe Han
IF: 7.169
1999-01-01
Acta Pharmacologica Sinica
Abstract:AIM: To determine the role of protein-tyrosine kinase (PTK) in α(1A)- adrenoceptor-mediated increase of [Ca2+](i) (intracellular calcium) in human embryo kidney (HEK) 293 cells expressed α(1A)-adrenoceptor. METHODS: Effects of two PTK inhibitors: genistein and tyrphostin, were investigated on the increase of [Ca2+](i) by using Fura-2. The activity of PTK was measured and the accumulation of [3H] InsPs were observed. RESULTS: Norepinephrine stimulated a rapid increase in [Ca2+](i) to (371 ± 31) nmol · L-1 in HEK 293 cells. Norepinephrine-induced increase of [Ca2+](i) was inhibited by the tyrosine kinase inhibitors quercetin and tyrphostin by 23.8% and 21.4%, respectively, but the accumulation of [3H]InPs induced by norepinephrine was not. The activity of the plasma-associated tyrosine kinase was increased to (1.73 ± 0.72)-fold over the control by norepinephrine 10 μmol · L-1. The norepinephrine-activated PTK was inhibited by calphostin C and depletion of intra- and extra-cellular Ca2+. CONCLUSION: The PTK participates in mobilization of Ca2+ mediated by α(1A)-adrenoceptors in HEK 293 cell lines.
What problem does this paper attempt to address?